Navigation Links
MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"
Date:11/19/2009

MUNSTER, Germany, November 19 /PRNewswire/ -- MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a serious burden to some of those affected, since it may be disabling for the patients and preventing them from receiving optimal treatment for Parkinson's.

Flibanserin is a 5-HT1a agonist and a 5-HT2a antagonist and thus fits in with the current theory on levodopa-induced dysinesia that dyskinesia is caused by the release of dopamine from serotonergic neurons. MONITORING FORCE is preparing to file another orphan drug status application with the United States Food and Drug Administration (FDA) and expects the first clinical trial in Parkinson's patients to start by mid-2010.

MONITORING FORCE GmbH is a clinical research company based in Munster/Germany with affiliates in the United States, France, Italy and other countries. MONITORING FORCE does contract research for the pharmaceutical industry as well as re-purposing drug development projects on their own. MONITORING FORCE has been founded in Germany in 1995 and spread to other countries since. Parkinson's disease is a primary focus of the company.

    Contact (Company): Dr. Jurgen Beck

    General Manager, MONITORING FORCE GmbH
    Bahnhofstrasse 111, 48143 Munster, Germany
    Tel.: +49-251-214-01-30, +49-251-26-39-577 (DD)
    Fax: +49-251-21-401-53-9, Mobile: +49-171-869-82-40
    beck@monitoring-force.com,  target='_blank' title='http://www.monitoring-force.eu

'>http://www.monitoring-force.eu

    Contact (Media): Aysun Ertan
    Project Manager, Targa Communications
    Goethestrasse 22, 60313 Frankfurt am Main, Germany
    Tel.: +49-69-66-36-83-98, Fax: +49-69-66-36-83-99
    ae@targacommunications.de,  target='_blank' title='http://www.targacommunications.de

'>http://www.targacommunications.de

SOURCE MONITORING FORCE GmbH


'/>"/>
SOURCE MONITORING FORCE GmbH
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
2. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
3. Medication Telemonitoring Improves Compliance and Behavior in NIH Study
4. Monitoring water through a snakes eyes
5. Bayers CONTOUR and Bayers BREEZE2 Blood Glucose Monitoring Systems Do Not Use Problematic GDH-PQQ Technology
6. Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer
7. Monitoring water through a snakes eyes
8. Unisense FertiliTech A/S Receives CE Mark of Approval for EmbryoScope(TM) Embryo Monitoring System
9. Serial Monitoring With ImmuKnow(R) is Useful in the Risk Assessment of Kidney Transplant Recipients
10. Monitoring water through a snakes eyes
11. Sixth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Chronic Care Management & Wellness Promotion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... months ended December 31, 2016. SQI is ... company that develops and commercializes proprietary technologies and products for ... ... milestones achieved in fiscal 2016," said Andrew Morris , ...
(Date:2/21/2017)... ... 21, 2017 , ... The medical potential of stem cells is both extensive ... medicine, due to their differentiating characteristics. Stem cells are unique as the have the ... induced to become tissue or organic-specific cells with special functions. , Stem cell ...
(Date:2/21/2017)... Feb. 21, 2017  Lexus, a returning partner of the ... official and exclusive automobile partner of the men,s and women,s events ... The 2017 Amgen Tour of California ... some of the best professional cycling teams in the world racing ... The four-day Amgen Breakaway from Heart Disease TM ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... that it has been approved for full, active membership in the Canadian Direct ... was founded by Chief Executive Officer Jeff Olson in 2011. Today ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/10/2017)... , Feb 10, 2017 ... new report "Personalized Medicine - Scientific and Commercial Aspects" ... ... personalized medicine. Diagnosis is integrated with therapy for selection of ... on early detection and prevention of disease in modern medicine. ...
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
Breaking Biology News(10 mins):